Sensodyne maker Haleon to raise stake in China JV
(Reuters) -Haleon plans to increase its stake in its Chinese joint venture to 88% from 55%, the British consumer healthcare company said on Friday. It will pay 4.47 billion yuan ($637 million) to buy the stake from partners Tianjin Pharmaceutical Group (TPG) and Tianjin Pharmaceutical Da Ren Tang Group (DRTG),